Aminex Therapeutics Inc.

United States of America (USA)

1 October 2018 - 30 September 2019

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Aminex Therapeutics Inc. published between 1 October 2018 - 30 September 2019 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.03

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0.03

Top articles by Altmetric score in current window

Article has an altmetric score of 260

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma

Science Translational Medicine

2019-01-30

1 October 2018 - 30 September 2019

International vs. domestic collaboration by Share

  • 11.46% Domestic
  • 88.54% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (4 total)

  • Aminex Therapeutics Inc., United States of America (USA)
  • Domestic institution
  1. Harvard University, United States of America (USA) (0.06)
    0.03
    0.03
  2. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA) (0.06)
    0.03
    0.03
  3. Children's Hospital of Philadelphia (CHOP), United States of America (USA) (0.05)
    0.03
    0.02
  4. University of Pennsylvania (Penn), United States of America (USA) (0.05)
    0.03
    0.02

Top 10 international collaborators by Share (10 total)

  • Aminex Therapeutics Inc., United States of America (USA)
  • Foreign institution
  1. Lowy Cancer Research Centre, Australia (0.46)
    0.03
    0.43
  2. University of New South Wales (UNSW Sydney), Australia (0.43)
    0.03
    0.40
  3. Children's Cancer Institute Australia (CCIA), Australia (0.24)
    0.03
    0.21
  4. University of Bologna (UNIBO), Italy (0.18)
    0.03
    0.15
  5. University of Cologne (UoC), Germany (0.09)
    0.03
    0.06
  6. Garvan Institute of Medical Research, Australia (0.06)
    0.03
    0.03
  7. NSW Health, Australia (0.06)
    0.03
    0.03
  8. University of Technology Sydney (UTS), Australia (0.04)
    0.03
    0.01
  9. NSW Health Pathology, Australia (0.04)
    0.03
    0.01
  10. Prince of Wales Private Hospital, Australia (0.04)
    0.03
    0.01

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Aminex Therapeutics Inc.
Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2019 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER